Rofecoxib for osteoarthritis

Overview of attention for article published in Cochrane database of systematic reviews, January 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

policy: 1 policy source

wikipedia: 3 Wikipedia pages

Citations

dimensions_citation: 36 Dimensions

Readers on

mendeley: 330 Mendeley

Summary Policy documents Wikipedia Dimensions citations

So far, Dimensions has found 36 publications that cite this research output.

36

The most recent citing publications are shown below. View all 36 publications that cite this research output on Dimensions.

Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations

Article in Gut (January 2020)

Some Cochrane risk-of-bias items are not important in osteoarthritis trials: a meta-epidemiological study based on Cochrane reviews

Article in Journal of Clinical Epidemiology (December 2017)

Celecoxib for osteoarthritis

Article in Cochrane Database of Systematic Reviews (May 2017)